Skip to main content
. 2018 Feb 14;8:2964. doi: 10.1038/s41598-018-21241-z

Figure 3.

Figure 3

The improvement of stool consistency and frequency in placebo and Clostridium butyricum (CB) groups. (a) No significant difference was found in change of Bristol stool scale from baseline to week 4 between the CB group and the placebo group (P = 0.259). (b) The reduction of stool frequency in CB group was significantly superior than that in the placebo group (P = 0.035). *P < 0.05.